Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients | Business Wire
Links shared publicly online about this topic.
- 0total visits
Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients | Business Wire
Pfizer Inc. (NYSE: PFE) announced today the top-line primary endpoint result for Toviaz (fesoterodine fumarate) Study A0221049 – Efficacy and Sa
View full resource at businesswire.com
Tags: Urinary System, Overactive Bladder, Overactive Bladder Medication, Senior Health, Toviaz, Pfizer, Bladder Dysfunction
Most Recently Shared on December 6, 2011 at 3:48 am By:
Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Eld... http://t.co/Mn0GIk9d
Also Shared By:
Advertisement
Urology & Nephrology
@Urology_Wisdom
Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Eld... http://t.co/EczZqQZb
1 year ago...